165 related articles for article (PubMed ID: 29088451)
1. RNA polymerase III-positive systemic sclerosis in a patient with circumscribed morphea.
Watson KD; Makol A
Rheumatology (Oxford); 2017 Nov; 56(11):1856. PubMed ID: 29088451
[No Abstract] [Full Text] [Related]
2. Inclusion body myositis in a patient with RNA polymerase III antibody-positive systemic sclerosis.
Vemulapalli S; Sharer LR; Hsu VM
J Rheumatol; 2015 Apr; 42(4):730-2. PubMed ID: 25834244
[No Abstract] [Full Text] [Related]
3. Localized scleroderma-like lesions induced by the Köbner phenomenon in a patient with systemic sclerosis positive for anticentromere antibody.
Asano Y; Sato S
Eur J Dermatol; 2020 Aug; 30(4):431-432. PubMed ID: 32808595
[No Abstract] [Full Text] [Related]
4. Guttate morphea in a scleroderma spectrum disorder patient with anticentromere antibody.
Yamanaka M; Ishikawa O
Eur J Dermatol; 2009; 19(6):630-1. PubMed ID: 19596641
[No Abstract] [Full Text] [Related]
5. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
Tanahashi K; Sugiura K; Muro Y; Akiyama M
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
[No Abstract] [Full Text] [Related]
6. Anti-RNA polymerase III antibody positive limited cutaneous systemic sclerosis with cryoglobulin-induced digital gangrene.
Deguchi A; Yamaoka T; Komurasaki Y; Hayashi M; Kiyohara E; Murota H; Katayama I
Clin Exp Dermatol; 2017 Mar; 42(2):200-201. PubMed ID: 27739106
[No Abstract] [Full Text] [Related]
7. Anti-RNA Polymerase II Antibodies in a U.S. Cohort of Systemic Sclerosis Patients: Comment on the Article by Hamaguchi et al.
Patel V; Assassi S; Mayes MD; Feghali-Bostwick CA
Arthritis Rheumatol; 2015 Sep; 67(9):2547-8. PubMed ID: 25988706
[No Abstract] [Full Text] [Related]
8. A case of anti-RNA polymerase III antibody-positive systemic sclerosis with generalized morphea-like lesions correlated with elevation of peripheral eosinophil counts.
Sasaoka Y; Kotobuki Y; Fujimoto R; Tonomura K; Nakagawa Y; Ueda-Hayakawa I; Tani M; Fujimoto M
J Dermatol; 2022 Nov; 49(11):e417-e418. PubMed ID: 35751638
[No Abstract] [Full Text] [Related]
9. Coexistence of morphea and systemic sclerosis.
Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
[TBL] [Abstract][Full Text] [Related]
10. Reply: To PMID 25512203.
Hamaguchi Y; Kuwana M; Fujimoto M
Arthritis Rheumatol; 2015 Sep; 67(9):2548. PubMed ID: 25988480
[No Abstract] [Full Text] [Related]
11. Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis.
Ceribelli A; Cavazzana I; Airò P; Franceschini F
J Rheumatol; 2010 Jul; 37(7):1544. PubMed ID: 20595295
[No Abstract] [Full Text] [Related]
12. [Scleroderma with special reference to generalized morphea].
Tanioku K; Fukushiro S
Nihon Rinsho; 1973 Dec; 31(12):3394-401. PubMed ID: 4799679
[No Abstract] [Full Text] [Related]
13. Clinical and laboratory features of systemic sclerosis complicated with localized scleroderma.
Toki S; Motegi S; Yamada K; Uchiyama A; Kanai S; Yamanaka M; Ishikawa O
J Dermatol; 2015 Mar; 42(3):283-7. PubMed ID: 25582037
[TBL] [Abstract][Full Text] [Related]
14. Anti-RNA polymerase III antibodies are associated with scleroderma renal crisis in a French cohort.
Emilie S; Goulvestre C; Bérezné A; Pagnoux C; Guillevin L; Mouthon L
Scand J Rheumatol; 2011; 40(5):404-6. PubMed ID: 21623662
[No Abstract] [Full Text] [Related]
15. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
[TBL] [Abstract][Full Text] [Related]
16. Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies.
Rosato E; Navarini L; Gigante A; Cianci R; Margiotta D; Barbano B; Afeltra A
Rheumatology (Oxford); 2017 Jun; 56(6):1039-1041. PubMed ID: 28340199
[No Abstract] [Full Text] [Related]
17. Antihistone antibodies in scleroderma.
Parodi A; Drosera M; Barbieri L; Rebora A
Dermatology; 1995; 191(1):16-8. PubMed ID: 8589476
[TBL] [Abstract][Full Text] [Related]
18. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
19. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.
Cavazzana I; Ceribelli A; Airo' P; Zingarelli S; Tincani A; Franceschini F
Autoimmun Rev; 2009 Jun; 8(7):580-4. PubMed ID: 19393210
[TBL] [Abstract][Full Text] [Related]
20. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
